Discovering Microbiome Insights for Better Health with Viome
Unlocking Microbiome Insights
Inside our bodies lies a flourishing ecosystem of microorganisms. This microbiome of bacteria and viruses profoundly impacts our health, and companies like Viome Life Sciences are leveraging it for personalized well-being. By utilizing proprietary technology, Viome analyzes saliva, stool, or blood to produce detailed health reports and personalized dietary and supplement recommendations.
Technology Driving Health Improvements
Viome founder Naveen Jain emphasizes the innovative approach of utilizing RNA sequencing to understand microbiome compositions effectively. By comparing individual data with a vast sample, Viome enhances disease risk prediction and health guidance. With over 400,000 customers and significant investor interest, Viome is poised to make a notable impact in the health tech landscape. Recently, the company secured a $25 million funding round, fostering further growth.
- Company Founded: 2016
- Funding Total: $200 million
- Key Investors: Khosla Ventures, Bold Capital, Marc Benioff
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.